Cargando…
Mir-34: A New Weapon Against Cancer?
The microRNA(miRNA)-34a is a key regulator of tumor suppression. It controls the expression of a plethora of target proteins involved in cell cycle, differentiation and apoptosis, and antagonizes processes that are necessary for basic cancer cell viability as well as cancer stemness, metastasis, and...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222652/ https://www.ncbi.nlm.nih.gov/pubmed/25247240 http://dx.doi.org/10.1038/mtna.2014.47 |
_version_ | 1782343076010786816 |
---|---|
author | Misso, Gabriella Di Martino, Maria Teresa De Rosa, Giuseppe Farooqi, Ammad Ahmad Lombardi, Angela Campani, Virginia Zarone, Mayra Rachele Gullà, Annamaria Tagliaferri, Pierosandro Tassone, Pierfrancesco Caraglia, Michele |
author_facet | Misso, Gabriella Di Martino, Maria Teresa De Rosa, Giuseppe Farooqi, Ammad Ahmad Lombardi, Angela Campani, Virginia Zarone, Mayra Rachele Gullà, Annamaria Tagliaferri, Pierosandro Tassone, Pierfrancesco Caraglia, Michele |
author_sort | Misso, Gabriella |
collection | PubMed |
description | The microRNA(miRNA)-34a is a key regulator of tumor suppression. It controls the expression of a plethora of target proteins involved in cell cycle, differentiation and apoptosis, and antagonizes processes that are necessary for basic cancer cell viability as well as cancer stemness, metastasis, and chemoresistance. In this review, we focus on the molecular mechanisms of miR-34a-mediated tumor suppression, giving emphasis on the main miR-34a targets, as well as on the principal regulators involved in the modulation of this miRNA. Moreover, we shed light on the miR-34a role in modulating responsiveness to chemotherapy and on the phytonutrients-mediated regulation of miR-34a expression and activity in cancer cells. Given the broad anti-oncogenic activity of miR-34a, we also discuss the substantial benefits of a new therapeutic concept based on nanotechnology delivery of miRNA mimics. In fact, the replacement of oncosuppressor miRNAs provides an effective strategy against tumor heterogeneity and the selective RNA-based delivery systems seems to be an excellent platform for a safe and effective targeting of the tumor. |
format | Online Article Text |
id | pubmed-4222652 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-42226522014-11-13 Mir-34: A New Weapon Against Cancer? Misso, Gabriella Di Martino, Maria Teresa De Rosa, Giuseppe Farooqi, Ammad Ahmad Lombardi, Angela Campani, Virginia Zarone, Mayra Rachele Gullà, Annamaria Tagliaferri, Pierosandro Tassone, Pierfrancesco Caraglia, Michele Mol Ther Nucleic Acids Review The microRNA(miRNA)-34a is a key regulator of tumor suppression. It controls the expression of a plethora of target proteins involved in cell cycle, differentiation and apoptosis, and antagonizes processes that are necessary for basic cancer cell viability as well as cancer stemness, metastasis, and chemoresistance. In this review, we focus on the molecular mechanisms of miR-34a-mediated tumor suppression, giving emphasis on the main miR-34a targets, as well as on the principal regulators involved in the modulation of this miRNA. Moreover, we shed light on the miR-34a role in modulating responsiveness to chemotherapy and on the phytonutrients-mediated regulation of miR-34a expression and activity in cancer cells. Given the broad anti-oncogenic activity of miR-34a, we also discuss the substantial benefits of a new therapeutic concept based on nanotechnology delivery of miRNA mimics. In fact, the replacement of oncosuppressor miRNAs provides an effective strategy against tumor heterogeneity and the selective RNA-based delivery systems seems to be an excellent platform for a safe and effective targeting of the tumor. Nature Publishing Group 2014-09 2014-09-23 /pmc/articles/PMC4222652/ /pubmed/25247240 http://dx.doi.org/10.1038/mtna.2014.47 Text en Copyright © 2014 American Society of Gene & Cell Therapy http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
spellingShingle | Review Misso, Gabriella Di Martino, Maria Teresa De Rosa, Giuseppe Farooqi, Ammad Ahmad Lombardi, Angela Campani, Virginia Zarone, Mayra Rachele Gullà, Annamaria Tagliaferri, Pierosandro Tassone, Pierfrancesco Caraglia, Michele Mir-34: A New Weapon Against Cancer? |
title | Mir-34: A New Weapon Against Cancer? |
title_full | Mir-34: A New Weapon Against Cancer? |
title_fullStr | Mir-34: A New Weapon Against Cancer? |
title_full_unstemmed | Mir-34: A New Weapon Against Cancer? |
title_short | Mir-34: A New Weapon Against Cancer? |
title_sort | mir-34: a new weapon against cancer? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222652/ https://www.ncbi.nlm.nih.gov/pubmed/25247240 http://dx.doi.org/10.1038/mtna.2014.47 |
work_keys_str_mv | AT missogabriella mir34anewweaponagainstcancer AT dimartinomariateresa mir34anewweaponagainstcancer AT derosagiuseppe mir34anewweaponagainstcancer AT farooqiammadahmad mir34anewweaponagainstcancer AT lombardiangela mir34anewweaponagainstcancer AT campanivirginia mir34anewweaponagainstcancer AT zaronemayrarachele mir34anewweaponagainstcancer AT gullaannamaria mir34anewweaponagainstcancer AT tagliaferripierosandro mir34anewweaponagainstcancer AT tassonepierfrancesco mir34anewweaponagainstcancer AT caragliamichele mir34anewweaponagainstcancer |